agilon health Narrows Losses Amidst Robust Revenue Growth
Ticker: AGL · Form: 10-Q · Filed: Aug 4, 2025 · CIK: 1831097
| Field | Detail |
|---|---|
| Company | Agilon Health, Inc. (AGL) |
| Form Type | 10-Q |
| Filed Date | Aug 4, 2025 |
| Risk Level | medium |
| Sentiment | mixed |
Sentiment: mixed
Topics: Healthcare, Value-Based Care, Earnings, Growth Stock, 10-Q, Medical Services, Quarterly Report
Related Tickers: AGL, HUM, CNC, UNH
TL;DR
AGL is growing revenue fast and cutting losses, making it a strong play in value-based care.
AI Summary
agilon health, inc. reported a significant increase in total revenue for the three months ended June 30, 2025, reaching $1.85 billion, up from $1.42 billion in the prior-year period, representing a 30.3% increase. For the six months ended June 30, 2025, total revenue was $3.61 billion, a 29.4% increase from $2.79 billion in the same period of 2024. The company's net loss attributable to agilon health, inc. stockholders for the three months ended June 30, 2025, was $45.6 million, an improvement from a net loss of $58.9 million in the comparable 2024 period. The net loss for the six months ended June 30, 2025, was $98.7 million, compared to $115.3 million in the first half of 2024. Medical services revenue was the primary driver, growing to $1.84 billion for the quarter and $3.59 billion year-to-date. The company continues to expand its value-based care model, evidenced by the increase in total revenue and a narrowing net loss, indicating operational improvements despite continued investment in growth. Other operating revenue remained relatively stable at $1.2 million for the quarter and $2.4 million year-to-date.
Why It Matters
agilon health's continued revenue growth and narrowing losses signal a strengthening position in the competitive value-based care market, which could attract more investors seeking exposure to healthcare innovation. For employees, this indicates job stability and potential expansion as the company scales its operations. Customers, primarily healthcare providers and their patients, benefit from the company's focus on value-based care, potentially leading to improved health outcomes and more coordinated services. In a market increasingly shifting away from fee-for-service models, agilon health's performance suggests it is effectively executing its strategy, putting pressure on traditional healthcare providers to adapt or risk losing market share.
Risk Assessment
Risk Level: medium — While agilon health shows strong revenue growth, it continues to report significant net losses, with a net loss of $45.6 million for Q2 2025 and $98.7 million year-to-date. This sustained unprofitability, despite improvements, indicates ongoing financial risk. The company's reliance on expanding its value-based care model also exposes it to regulatory changes and the complexities of managing medical costs.
Analyst Insight
Investors should monitor agilon health's path to profitability closely, specifically looking for continued reductions in net loss and positive free cash flow in future filings. Consider AGL a growth stock with inherent risks, suitable for those with a higher risk tolerance and a long-term view on the value-based care sector.
Financial Highlights
- revenue
- $1.85B
- net Income
- -$45.6M
- revenue Growth
- +30.3%
Revenue Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Medical Services | $1.84B | |
| Medical Services | $3.59B | |
| Other Operating Revenue | $1.2M | |
| Other Operating Revenue | $2.4M |
Key Numbers
- $1.85B — Total Revenue (Increased 30.3% for Q2 2025 compared to Q2 2024)
- $3.61B — Total Revenue (Increased 29.4% for H1 2025 compared to H1 2024)
- $45.6M — Net Loss (Improved from $58.9M in Q2 2024 to $45.6M in Q2 2025)
- $98.7M — Net Loss (Improved from $115.3M in H1 2024 to $98.7M in H1 2025)
- 30.3% — Revenue Growth (Year-over-year increase in total revenue for Q2 2025)
Key Players & Entities
- agilon health, inc. (company) — filer of the 10-Q
- $1.85 billion (dollar_amount) — total revenue for Q2 2025
- $1.42 billion (dollar_amount) — total revenue for Q2 2024
- $3.61 billion (dollar_amount) — total revenue for H1 2025
- $2.79 billion (dollar_amount) — total revenue for H1 2024
- $45.6 million (dollar_amount) — net loss for Q2 2025
- $58.9 million (dollar_amount) — net loss for Q2 2024
- $98.7 million (dollar_amount) — net loss for H1 2025
- $115.3 million (dollar_amount) — net loss for H1 2024
- SEC (regulator) — recipient of the 10-Q filing
FAQ
What were agilon health's total revenues for the second quarter of 2025?
agilon health, inc. reported total revenues of $1.85 billion for the three months ended June 30, 2025, a significant increase from $1.42 billion in the same period of 2024.
How did agilon health's net loss change in Q2 2025 compared to Q2 2024?
The net loss attributable to agilon health, inc. stockholders improved to $45.6 million for the three months ended June 30, 2025, from a net loss of $58.9 million in the comparable 2024 period.
What was the primary driver of agilon health's revenue growth in the first half of 2025?
Medical services revenue was the primary driver, growing to $3.59 billion for the six months ended June 30, 2025, contributing significantly to the overall revenue increase.
Is agilon health profitable as of the Q2 2025 filing?
No, agilon health, inc. is not yet profitable, reporting a net loss of $45.6 million for Q2 2025 and $98.7 million for the first half of 2025, though these losses have narrowed compared to the prior year.
What is agilon health's strategic outlook based on this 10-Q?
The strategic outlook for agilon health, inc. appears focused on continued expansion of its value-based care model, leveraging strong revenue growth to eventually achieve profitability, as indicated by the narrowing net losses.
What are the key risks for agilon health investors highlighted in the 10-Q?
Key risks include the company's sustained unprofitability, with a net loss of $98.7 million year-to-date, and the inherent complexities and regulatory risks associated with managing medical costs in a value-based care model.
How does agilon health's performance impact the broader healthcare market?
agilon health's strong revenue growth in value-based care demonstrates the viability and increasing adoption of this model, potentially accelerating the shift away from traditional fee-for-service structures across the healthcare industry.
What should investors consider regarding agilon health's stock (AGL)?
Investors should consider AGL a growth stock with medium risk, suitable for those with a long-term perspective on the value-based care sector, and should closely monitor its progress towards sustained profitability.
Did agilon health report any significant changes in its other operating revenue?
agilon health, inc.'s other operating revenue remained relatively stable, reporting $1.2 million for the three months ended June 30, 2025, and $2.4 million for the six months ended June 30, 2025.
What is agilon health's Central Index Key (CIK) according to the filing?
agilon health, inc.'s Central Index Key (CIK) is 0001831097, as stated in the 10-Q filing.
Industry Context
Agilon Health operates within the rapidly evolving healthcare sector, focusing on value-based care models. This segment is characterized by increasing regulatory oversight and a shift towards patient outcomes over service volume. The competitive landscape includes other managed care organizations and healthcare providers adapting to these value-based arrangements.
Regulatory Implications
The company's operations are subject to healthcare regulations, including those governing Medicare Advantage and other government programs. Changes in reimbursement policies or compliance requirements could materially impact financial performance. Agilon's focus on value-based care aligns with broader healthcare policy trends but also necessitates continuous adaptation to regulatory frameworks.
What Investors Should Do
- Monitor medical loss ratio trends.
- Evaluate the scalability of the model.
Glossary
- Value-based care
- A healthcare delivery model where providers are reimbursed based on the quality of care they provide, rather than the quantity of services rendered. (Agilon Health's core business model, driving its revenue growth and operational strategy.)
Year-Over-Year Comparison
Compared to the prior-year period, agilon health, inc. demonstrated robust revenue growth, with total revenue increasing by 30.3% for the quarter ended June 30, 2025, reaching $1.85 billion. This growth was primarily driven by its Medical Services segment. Concurrently, the company has shown progress in reducing its net loss, which narrowed from $58.9 million in Q2 2024 to $45.6 million in Q2 2025, indicating operational improvements alongside its expansion efforts.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on August 4, 2025 regarding agilon health, inc. (AGL).